肺癌在我国发病率和死亡率均居于首位。近十年来，分子检测技术的发展及靶向药物的治疗极大地改善了非小细胞肺癌（NSCLC）患者的预后。除了 EGFR、BRAF 等基因突变类型，在 NSCLC 中，存在许多融合基因，比如 ALK、ROS1、RET、NTRK 等。相应的融合基因靶向药物也 ...

Next-generation sequencing (NGS) has transformed the medical and biological sciences, providing improved throughput and affordability. The cost of whole-genome sequencing has reduced considerably, ...

Targeted next-generation sequencing (NGS) is often performed using hybridization-based target enrichment, which deploys oligonucleotide probes to capture regions of interest for downstream sequencing.

The Next Generation Sequencing (NGS) library preparation process is labor-intensive, requiring experience and attention to detail over hours. Eppendorf is introducing a complete package of epMotion ...

In a hypothetical 1,000,000-member health plan, 2,066 Medicare-insured patients and 156 commercially insured patients were estimated to have mNSCLC and to be eligible for testing. Time-to-test results ...

We reviewed electronic medical records of patients with newly diagnosed, untreated metastatic NSCLC from December 2018 to August 2021 and determined the number of days from pathologic diagnosis to NGS ...